September 2020 FDA Recall Drug by Teligent Pharma, Inc.
D-0064-2021 - Failed Impurities/Degradation - Out-of-specification results for Fluocinolone Acetonide impurity.

This Class III drug recall was voluntarily initiated by Teligent Pharma, Inc. on September 28, 2020 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation - out-of-specification results for fluocinolone acetonide impurity.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0064-2021

Reason for Recall
Failed Impurities/Degradation - Out-of-specification results for Fluocinolone Acetonide impurity.
Initiated
09-28-2020
Reported
11-11-2020
Quantity
36,790 tubes

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Teligent Pharma, Inc.
United States Nationwide
Fluocinonide Ointment USP 0.05%, packaged in: a) 15 gm tube, NDC 52565-0040-15, b) 30 gm tube, NDC 52565-0040-30 c) 60 gram tube, NDC 52565-0040-60, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, New Jersey 08310

Batch or Lot Expiration Information

Lot# : a) 12250, Exp 10/2020; 15039, Exp 1/2022; 15573, Exp 7/2022; b) 12250, Exp 10/2020; 14589, 14848, Exp 12/2021; 15039, Exp 1/2022; 15245, Exp 2/2022; c) 12241, 12249, Exp 10/2020; 14222, Exp 8/2021; 15039, Exp 1/2022; 15037, 15246, Exp 2/2022; 15340, Exp 3/2022; 15387, Exp 4/2022